Tralokinumab Interactions
There are 167 drugs known to interact with tralokinumab, along with 3 disease interactions. Of the total drug interactions, 41 are major, 119 are moderate, and 7 are minor.
- View all 167 medications that may interact with tralokinumab
- View tralokinumab disease interactions (3)
Most frequently checked interactions
View interaction reports for tralokinumab and the medicines listed below.
- Antabuse (disulfiram)
- Centrum (multivitamin with minerals)
- Cibinqo (abrocitinib)
- Dymista (azelastine / fluticasone nasal)
- Eucrisa (crisaborole topical)
- Jakafi (ruxolitinib)
- NPH Insulin (insulin isophane)
- Olumiant (baricitinib)
- Opzelura (ruxolitinib topical)
- Ozempic (semaglutide)
- Peridex (chlorhexidine topical)
- Remicade (infliximab)
- Rinvoq (upadacitinib)
- Seroquel (quetiapine)
- Vitamin B1 (thiamine)
- Vitamin D3 (cholecalciferol)
- Vyvanse (lisdexamfetamine)
- Wellbutrin XL (bupropion)
- Xarelto (rivaroxaban)
- Xeljanz (tofacitinib)
Tralokinumab disease interactions
There are 3 disease interactions with tralokinumab which include:
More about tralokinumab
- tralokinumab consumer information
- Compare alternatives
- Reviews (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.